GlassScriptPhysician profile
Angela Akonye
NPI 1912942673
$1,807.10
in general payments reported to CMS, 2019-2025
23 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $116 · 2021: $524 · 2022: $153 · 2023: $247 · 2024: $216 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $370.22 | 2019-2023 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $141.33 | 2021-2025 | |
| Exeltis, USA INC. | $133.57 | 2020-2022 | |
| Novo Nordisk INC | $124.99 | 2023 | Wegovy |
| Hologic Sales and Service, LLC | $109.92 | 2019-2024 | Aptima |
| Ethicon US, LLC | $104.05 | 2021-2025 | Enseal |
| Organon LLC | $103.76 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $91.11 | 2019-2025 | Gardasil 9 |
| Avion Pharmaceuticals | $75.53 | 2020-2023 | Balcoltra |
| Shield Therapeutics INC | $66.63 | 2023-2025 | Accrufer |
| Coopersurgical, INC. | $64.67 | 2019-2025 | Paragard T 380a |
| Therapeuticsmd, INC. | $57.62 | 2021-2022 | |
| Minerva Surgical, INC | $51.25 | 2019 | |
| Smith+Nephew, INC. | $48.56 | 2022 | |
| Millicent US INC | $38.56 | 2025 | Intrarosa, Femlyv |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $37.51 | 2025 | Zurzuvae |
| Mission Pharmacal Company | $35.72 | 2020 | |
| Agile Therapeutics, INC. | $31.96 | 2021 | |
| Allergan, INC. | $28.48 | 2021 | |
| Meditrina | $28.10 | 2023-2025 | |
| Aspira Women'S Health INC | $24.64 | 2024 | Ova1 |
| Myovant Sciences INC. | $19.92 | 2021 | |
| Pfizer INC. | $19.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Akonye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.